ArticleKidney medicine2025

Utilization Trends of Dual GIP/GLP-1 Receptor Agonist, Newer Glucose-Lowering Medications, and Anti-Obesity Medications Among Patients With Chronic Kidney Disease With and Without Type 2 Diabetes.

Panupong Hansrivijit et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.